|
1
|
Munksgaard PS and Blaakaer J: The
association between endometriosis and gynecological cancers and
breast cancer: A review of epidemiological data. Gynecol Oncol.
123:157–63. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hsiao KY, Wu MH and Tsai SJ: Epigenetic
regulation of the pathological process in endometriosis. Reprod Med
Biol. 16:314–319. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Busacca M and Vignali M: Ovarian
endometriosis: From pathogenesis to surgical treatment. Curr Opin
Obstet Gynecol. 15:321–326. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sampson JA: Metastatic or embolic
endometriosis, due to the menstrual dissemination of endometrial
tissue into the venous circulation. Am J Pathol. 3:93–110.43.
1927.PubMed/NCBI
|
|
5
|
Jiang X, Hitchcock A, Bryan EJ, Watson RH,
Englefield P, Thomas EJ and Campbell IG: Microsatellite analysis of
endometriosis reveals loss of heterozygosity at candidate ovarian
tumor suppressor gene loci. Cancer Res. 56:3534–3539.
1996.PubMed/NCBI
|
|
6
|
Scarfone G, Bergamini A, Noli S, Villa A,
Cipriani S, Taccagni G, Vigano' P, Candiani M, Parazzini F and
Mangili G: Characteristics of clear cell ovarian cancer arising
from endometriosis: A two center cohort study. Gynecol Oncol.
133:480–484. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kvaskoff M, Mu F, Terry KL, Harris HR,
Poole EM, Farland L and Missmer SA: Endometriosis: A high-risk
population for major chronic diseases? Hum Reprod Update.
21:500–516. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pearce CL, Templeman C, Rossing MA, Lee A,
Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund
KG, et al: Association between endometriosis and risk of
histological subtypes of ovarian cancer: A pooled analysis of
case-control studies. Lancet Oncol. 13:385–394. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee AW, Templeman C, Stram DA, Beesley J,
Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G and Pearce CL:
Ovarian Cancer Association Consortium. Evidence of a genetic link
between endometriosis and ovarian cancer. Fertil Steril.
105:35–43.e1-e10. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lu Y, Cuellar-Partida G, Painter JN and
Nyholt DR: Australian Ovarian Cancer Study; International Endogene
Consortium (IEC). Morris AP, Fasching PA, Hein A, Burghaus S, et
al: Shared genetics underlying epidemiological association between
endometriosis and ovarian cancer. Hum Mol Genet. 24:5955–5964.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sayasneh A, Tsivos D and Crawford R:
Endometriosis and ovarian cancer: A systematic review. ISRN Obstet
Gynecol. 2011(140310)2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Heidemann LN, Hartwell D, Heidemann CH and
Jochumsen KM: The relation between endometriosis and ovarian
cancer-a review. Acta Obstet Gynecol Scand. 93:20–31.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nezhat FR, Apostol R, Nezhat C and Pejovic
T: New insights in the pathophysiology of ovarian cancer and
implications for screening and prevention. Am J Obstet Gynecol.
213:262–267. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zafrakas M, Grimbizis G, Timologou A and
Tarlatzis BC: Endometriosis and ovarian cancer risk: A systematic
review of epidemiological studies. Front Surg. 1(14)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sauriol A, Simeone K, Portelance L,
Meunier L, Leclerc-Desaulniers K, de Ladurantaye M, Chergui M,
Kendall-Dupont J, Rahimi K, Carmona E, et al: Modeling the
diversity of epithelial ovarian cancer through ten novel well
characterized cell lines covering multiple subtypes of the disease.
Cancers (Basel). 12(2222)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Webb PM and Jordan SJ: Epidemiology of
epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol.
41:3–14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gray S, Khor XY and Yiannakis D: Niraparib
as maintenance therapy in a patient with ovarian cancer and brain
metastases. BMJ Case Rep. 12(e230738)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guo SW: Endometriosis and ovarian cancer:
Potential benefits and harms of screening and risk-reducing
surgery. Fertil Steril. 104:813–830. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Braicu OL, Budisan L, Buiga R, Jurj A,
Achimas-Cadariu P, Pop LA, Braicu C, Irimie A and Berindan-Neagoe
I: miRNA expression profiling in formalin-fixed paraffin-embedded
endometriosis and ovarian cancer samples. Onco Targets Ther.
10:4225–4238. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Saare M, Rekker K, Laisk-Podar T,
Rahmioglu N, Zondervan K, Salumets A, Götte M and Peters M:
Challenges in endometriosis miRNA studies-From tissue heterogeneity
to disease specific miRNAs. Biochim Biophys Acta Mol Basis Dis.
1863:2282–2292. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Braicu C, Catana C, Calin GA and
Berindan-Neagoe I: NCRNA combined therapy as future treatment
option for cancer. Curr Pharm Des. 20:6565–6574. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hamberg M, Backes C, Fehlmann T, Hart M,
Meder B, Meese E and Keller A: MiRTargetLink-miRNAs, genes and
interaction networks. Int J Mol Sci. 17(564)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Burney RO, Hamilton AE, Aghajanova L, Vo
KC, Nezhat CN, Lessey BA and Giudice LC: MicroRNA expression
profiling of eutopic secretory endometrium in women with versus
without endometriosis. Mol Hum Reprod. 15:625–631. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Forte A, Cipollaro M and Galderisi U:
Genetic, epigenetic and stem cell alterations in endometriosis: New
insights and potential therapeutic perspectives. Clin Sci (Lond).
126:123–138. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Verma GP: Fundamentals of histology. New
Delhi, New Age, 2001.
|
|
26
|
Cameron RI and Allen DC: Histopathology
specimens clinical, pathological and laboratory aspects. London,
Springer, 2005.
|
|
27
|
Nucci MR and Oliva E, (eds): Gynecologic
pathology: Edinburgh: Churchill Livingstone, (Foundations in
diagnostic pathology), pp710, 2009.
|
|
28
|
Grandi G, Toss A, Cortesi L, Botticelli L,
Volpe A and Cagnacci A: The association between endometriomas and
Ovarian Cancer: Preventive effect of inhibiting ovulation and
menstruation during reproductive life. Biomed Res Int.
2015(751571)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kurman RJ and Shih IM: Molecular
pathogenesis and extraovarian origin of epithelial ovarian
cancer-shifting the paradigm. Hum Pathol. 42:918–931.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kim HS, Kim TH, Chung HH and Song YS: Risk
and prognosis of ovarian cancer in women with endometriosis: A
meta-analysis. Br J Cancer. 110:1878–1890. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
McCluggage WG: Morphological subtypes of
ovarian carcinoma: A review with emphasis on new developments and
pathogenesis. Pathology. 43:420–432. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Worley MJ, Welch WR, Berkowitz RS and Ng
SW: Endometriosis-associated ovarian cancer: A review of
pathogenesis. Int J Mol Sci. 14:5367–5379. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fukunaga M, Nomura K, Ishikawa E and
Ushigome S: Ovarian atypical endometriosis: Its close association
with malignant epithelial tumours. Histopathology. 30:249–255.
1997.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ballouk F, Ross JS and Wolf BC: Ovarian
endometriotic cysts. An analysis of cytologic atypia and DNA ploidy
patterns. Am J Clin Pathol. 102:415–419. 1994.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chene G, Ouellet V, Rahimi K, Barres V,
Provencher D and Mes-Masson AM: The ARID1A pathway in ovarian clear
cell and endometrioid carcinoma, contiguous endometriosis, and
benign endometriosis. Int J Gynaecol Obstet. 130:27–30.
2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Worley MJ Jr, Liu S, Hua Y, Kwok JS,
Samuel A, Hou L, Shoni M, Lu S, Sandberg EM, Keryan A, et al:
Molecular changes in endometriosis-associated ovarian clear cell
carcinoma. Eur J Cancer. 51:1831–1842. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pavlidou A and Vlahos NF: Endometriosis
and ovarian cancer: Clinical and molecular aspects. Minerva
Endocrinol. 39:155–165. 2014.PubMed/NCBI
|
|
38
|
Matsumoto T, Yamazaki M, Takahashi H,
Kajita S, Suzuki E, Tsuruta T and Saegusa M: Distinct β-catenin and
PIK3CA mutation profiles in endometriosis-associated ovarian
endometrioid and clear cell carcinomas. Am J Clin Pathol.
144:452–463. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Govatati S, Challa K, Reddy SB, Pramod K,
Deenadayal M, Chakravarty B, Shivaji S and Bhanoori M: BRCA1
alterations are associated with endometriosis, but BRCA2
alterations show no detectable endometriosis risk: A study in
Indian population. J Assist Reprod Genet. 32:277–285.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sáinz de la Cuesta R, Izquierdo M,
Cañamero M, Granizo JJ and Manzarbeitia F: Increased prevalence of
p53 overexpression from typical endometriosis to atypical
endometriosis and ovarian cancer associated with endometriosis. Eur
J Obstet Gynecol Reprod Biol. 113:87–93. 2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Dawson A, Fernandez ML, Anglesio M, Yong
PJ and Carey MS: Endometriosis and endometriosis-associated
cancers: Aew insights into the molecular mechanisms of ovarian
cancer development. Ecancermedicalscience. 12(803)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wei JJ, William J and Bulun S:
Endometriosis and ovarian cancer: A review of clinical, pathologic,
and molecular aspects. Int J Gynecol Pathol. 30:553–568.
2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lakhani SR, Manek S, Penault-Llorca F,
Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P,
Klijn JG, et al: Pathology of ovarian cancers in BRCA1 and BRCA2
carriers. Clin Cancer Res. 10:2473–2481. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
King CM, Barbara C, Prentice A, Brenton JD
and Charnock-Jones DS: Models of endometriosis and their utility in
studying progression to ovarian clear cell carcinoma. J Pathol.
238:185–196. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Bayramoğlu H and Düzcan E: Atypical
epithelial changes and mutant p53 gene expression in ovarian
endometriosis. Pathol Oncol Res. 7:33–38. 2001.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Aviel-Ronen S, Soriano D, Shmuel E,
Schonman R, Rosenblatt K, Zadok O, Vituri A, Seidman D, Barshack I
and Cohen Y: Surgically treated ovarian endometriosis association
with BRCA1 and BRCA2 mutations. Pathol Res Pract. 210:250–255.
2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Stewart CJ, Leung Y, Walsh MD, Walters RJ,
Young JP and Buchanan DD: KRAS mutations in ovarian low-grade
endometrioid adenocarcinoma: Association with concurrent
endometriosis. Hum Pathol. 43:1177–1183. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Wang F, Chen C and Wang D: Circulating
microRNAs in cardiovascular diseases: From biomarkers to
therapeutic targets. Front Med. 8:404–418. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Absalon S, Kochanek DM, Raghavan V and
Krichevsky AM: MiR-26b, upregulated in Alzheimer's disease,
activates cell cycle entry, tau-phosphorylation, and apoptosis in
postmitotic neurons. J Neurosci. 33:14645–14659. 2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Miñones-Moyano E, Porta S, Escaramís G,
Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I,
Estivill X and Martí E: MicroRNA profiling of Parkinson's disease
brains identifies early downregulation of miR-34b/c which modulate
mitochondrial function. Hum Mol Genet. 20:3067–3078.
2011.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Beuzelin D and Kaeffer B: Exosomes and
miRNA-Loaded biomimetic nanovehicles, a focus on their potentials
preventing type-2 diabetes linked to metabolic syndrome. Front
Immunol. 9(2711)2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sung J, Wang Y, Chandrasekaran S, Witten
DM and Price ND: Molecular signatures from omics data: From chaos
to consensus. Biotechnol J. 7:946–957. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Coutinho LM, Ferreira MC, Rocha ALL,
Carneiro MM and Reis FM: New biomarkers in endometriosis. Adv Clin
Chem. 89:59–77. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ahn SH, Singh V and Tayade C: Biomarkers
in endometriosis: Challenges and opportunities. Fertil Steril.
107:523–532. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Rekker K, Saare M, Roost AM, Kaart T,
Sõritsa D, Karro H, Sõritsa A, Simón C, Salumets A and Peters M:
Circulating miR-200-family micro-RNAs have altered plasma levels in
patients with endometriosis and vary with blood collection time.
Fertil Steril. 104:938–946.e2. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Agrawal S, Tapmeier T, Rahmioglu N,
Kirtley S, Zondervan K and Becker C: The miRNA Mirage: How close
are we to finding a non-invasive diagnostic biomarker in
endometriosis? A systematic review. Int J Mol Sci.
19(599)2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Jia SZ, Yang Y, Lang J, Sun P and Leng J:
Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women
with endometriosis. Hum Reprod. 28:322–330. 2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Nisenblat V, Sharkey DJ, Wang Z, Evans SF,
Healey M, Ohlsson Teague EMC, Print CG, Robertson SA and Hull ML:
Plasma miRNAs display limited potential as diagnostic tools for
endometriosis. J Clin Endocrinol Metab. 104:1999–2022.
2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Tomuleasa C, Braicu C, Irimie A, Craciun L
and Berindan-Neagoe I: Nanopharmacology in translational hematology
and oncology. Int J Nanomedicine. 9:3465–3479. 2014.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ross JS, Carlson JA and Brock G: miRNA:
The new gene silencer. Am J Clin Pathol. 128:830–836.
2007.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Cancer Genome Atlas Research Network.
Integrated genomic analyses of ovarian carcinoma. Nature.
474:609–615. 2011.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Zhang M, Wang S, Tang L, Wang X, Zhang T,
Xia X and Fang X: Downregulated circular RNA hsa_circ_0067301
regulates epithelial-mesenchymal transition in endometriosis via
the miR-141/Notch signaling pathway. Biochem Biophys Res Commun.
514:71–77. 2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Cao J, Cai J, Huang D, Han Q, Chen Y, Yang
Q, Yang C, Kuang Y, Li D and Wang Z: miR-335 represents an
independent prognostic marker in epithelial ovarian cancer. Am J
Clin Pathol. 141:437–442. 2014.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu T, Qin W, Hou L and Huang Y:
MicroRNA-17 promotes normal ovarian cancer cells to cancer stem
cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
Tumour Biol. 36:1881–1893. 2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Corney DC, Hwang CI, Matoso A, Vogt M,
Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH,
Hermeking H and Nikitin AY: Frequent downregulation of miR-34
family in human ovarian cancers. Clin Cancer Res. 16:1119–1128.
2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Qu W, Chen X, Wang J, Lv J and Yan D:
MicroRNA-1 inhibits ovarian cancer cell proliferation and migration
through c-Met pathway. Clin Chim Acta. 473:237–244. 2017.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Gulei D, Raduly L, Broseghini E, Ferracin
M and Berindan-Neagoe I: The extensive role of miR-155 in malignant
and non-malignant diseases. Mol Aspects Med. 70:33–56.
2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Liu HY, Zhang YY, Zhu BL, Feng FZ, Yan H,
Zhang HY and Zhou B: miR-21 regulates the proliferation and
apoptosis of ovarian cancer cells through PTEN/PI3K/AKT. Eur Rev
Med Pharmacol Sci. 23:4149–4155. 2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Miao C, Zhang J, Zhao K, Liang C, Xu A,
Zhu J, Wang Y, Hua Y, Tian Y, Liu S, et al: The significance of
microRNA-148/152 family as a prognostic factor in multiple human
malignancies: A meta-analysis. Oncotarget. 8:43344–43355.
2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Xiong Y, Liu Y, Xiong W, Zhang L, Liu H,
Du Y and Li N: Hypoxia-inducible factor 1α-induced
epithelial-mesenchymal transition of endometrial epithelial cells
may contribute to the development of endometriosis. Hum Reprod.
31:1327–1338. 2016.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Du Y, Zhang Z, Xiong W, Li N, Liu H, He H,
Li Q, Liu Y and Zhang L: Estradiol promotes EMT in endometriosis
via MALAT1/miR200s sponge function. Reproduction. 157:179–188.
2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Ren T, Wang S, Sun J, Qu JM, Xiang Y, Shen
K and Lang JH: Endometriosis is the independent prognostic factor
for survival in Chinese patients with epithelial ovarian carcinoma.
J Ovarian Res. 10(67)2017.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Barreta A, Sarian L, Ferracini AC, Eloy L,
Brito ABC, de Angelo Andrade L and Derchain S:
Endometriosis-associated ovarian cancer: Population characteristics
and prognosis. Int J Gynecol Cancer. 28:1251–1257. 2018.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Park JY, Kim DY, Suh DS, Kim JH, Kim YM,
Kim YT and Nam JH: Significance of ovarian endometriosis on the
prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer.
28:11–18. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Czernobilsky B and Morris WJ: A histologic
study of ovarian endometriosis with emphasis on hyperplastic and
atypical changes. Obstet Gynecol. 53:318–323. 1979.PubMed/NCBI
|
|
78
|
Ñiguez Sevilla I, Machado Linde F, Marín
Sánchez MDP, Arense JJ, Torroba A, Nieto Díaz A and Sánchez Ferrer
ML: Prognostic importance of atypical endometriosis with
architectural hyperplasia versus cytologic atypia in
endometriosis-associated ovarian cancer. J Gynecol Oncol.
30(e63)2019.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y,
Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et
al: ARID1A mutations in endometriosis-associated ovarian
carcinomas. N Engl J Med. 363:1532–1543. 2010.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kuo KT, Mao TL, Jones S, Veras E, Ayhan A,
Wang TL, Glas R, Slamon D, Velculescu VE, Kuman RJ and Shih IeM:
Frequent activating mutations of PIK3CA in ovarian clear cell
carcinoma. Am J Pathol. 174:1597–1601. 2009.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Sato N, Tsunoda H, Nishida M, Morishita Y,
Takimoto Y, Kubo T and Noguchi M: Loss of heterozygosity on 10q23.3
and mutation of the tumor suppressor gene PTEN in benign
endometrial cyst of the ovary: Possible sequence progression from
benign endometrial cyst to endometrioid carcinoma and clear cell
carcinoma of the ovary. Cancer Res. 60:7052–7056. 2000.PubMed/NCBI
|
|
82
|
Pavone ME and Lyttle BM: Endometriosis and
ovarian cancer: Links, risks, and challenges faced. Int J Womens
Health. 7:663–672. 2015.PubMed/NCBI View Article : Google Scholar
|
